State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Arkansas, Missouri – Oct 24

Key briefs were filed this week in state contract pharmacy litigation in Arkansas and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AstraZeneca Announces Change to Cancer Drug Replenishment After Discontinuing Certain Dosage

AstraZeneca recently posted an NDC notice to 340B covered entities regarding replenishment of a cancer medication.
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

UCB Extends Contract Pharmacy Restrictions to All Federal Grantees

UCB announced extended 340B contract pharmacy restrictions that will take effect Nov. 25.
Belgium pharmaceutical giant UCB is extending its 340B contract pharmacy restrictions to all federal grantees and adding new data submission [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Organon To Extend Contract Pharmacy Restrictions to CHCs on Dec. 1

Organon announced that, effective Dec. 1, it will extend its contract pharmacy restrictions to HRSA-funded health centers.
A New Jersey-based drugmaker announced this week that beginning in December, its 340B contract pharmacy restrictions will apply to Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Fifth Hospital Sues HRSA for Authorizing ‘Unlawful’ J&J 340B Audits

University of Washington Medical Center sued HRSA for authorizing an allegedly unlawful 340B program audit of the hospital.
A Washington state hospital on Tuesday became the fifth provider to sue the federal government for authorizing Johnson & Johnson [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Group That Does Not Disclose Its Funding Releases White Paper Calling for 340B Reforms, Advocates Slam Report

The Health Equity Collaborative called for 340B program overhauls in a new white paper.
An organization that describes itself as being “comprised of dozens of national, public health, patient advocacy and multicultural organizations,” but [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Growth in 340B Purchases Driven by Pharma Price Increases, Broader Healthcare Trends, Providers Say

Providers say drugmaker price increases and broader healthcare trends drove last year's increase in total 340B purchases.
The growth in total 340B purchases last year was largely a result of drugmaker price increases and broader healthcare trends, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Magic Johnson-Backed Startup Raises $31 Million to Help Build, Expand In-House Pharmacies at 340B HIV Clinics

Alchemy announced that it has raised $31 million, as part of a campaign with NBA legend Earvin “Magic” Johnson, to help build in-house pharmacies for HIV clinics. (Credit: Shutterstock)
A California-based healthcare startup recently announced that it has raised more than $30 million, as part of a campaign with [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Activity Did Not Slow Down in Q3, Federal Filings Suggest

340B Working Table
More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.
The 340B drug discount program continued to be a hot topic for lobbyists in the third quarter of 2024, keeping [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Total 340B Drug Purchases Reached $66 Billion in 2023

Total 340B purchases reached $66.3 billion in 2023, according to new HRSA data released Oct. 18.
Drug purchases under the 340B program reached $66.3 billion in 2023, marking a 24% increase over the $54 billion in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live